National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Clinical Trial Results

Summaries of Newsworthy Clinical Trial Results

< Back to Main

Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Browse by Cancer Type
Breast Cancer

Lung Cancer

Prostate Cancer

More Results
Search Trial Results

    Search  
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Restructuring the NCI Clinical Trials Enterprise

Clinical Trials Reporting Program

Coordinating Center for Clinical Trials

States Requiring Coverage of Clinical Trial Costs
Related Pages
Search for Clinical Trials
NCI's PDQ® Cancer Clinical Trials Registry.

Head and Neck Cancer Home Page
NCI's gateway for information about head and neck cancer.
Head and Neck Cancer Trial Results
6.  Frozen Glove Reduces Skin and Nail Damage from Docetaxel Chemotherapy
(Posted: 08/01/2005) - Patients who wore an experimental "frozen glove" to keep their hands very cold during intravenous chemotherapy with docetaxel (Taxotere®) had much less subsequent damage to the nails and skin of their hands, according to a study published in the July 1, 2005, issue of the Journal of Clinical Oncology.

7.  Vitamin E Does Not Help Head and Neck Cancer Patients
(Posted: 08/01/2005) - A large randomized study of patients treated with radiation therapy for head and neck cancer found that vitamin E supplements did not prevent the occurrence of second primary tumors and may be associated with an increased risk of cancer recurrence. The results demonstrate that vitamin E supplements are not beneficial to patients with stage I or II head and neck cancer.

8.  Docetaxel (Taxotere®) Before Radiation Extends Survival in Patients with Head and Neck Cancer
(Posted: 06/05/2004, Reviewed: 11/27/2007) - In a phase III study of patients with inoperable head and neck cancer, a multidrug chemotherapy regimen including the drug docetaxel (Taxotere®) that was given before radiation extended patients' survival by about four months, with fewer side effects, compared to standard therapy.

9.  Combined Therapy May Offer Advantage in Head and Neck Cancer
(Posted: 06/02/2004) - Patients with head and neck cancer who were treated with chemotherapy in addition to radiation after surgery had fewer recurrences of disease and longer disease-free survival than patients who were treated with radiation alone after surgery, two randomized clinical trials have found.

10.  Chemotherapy and Radiation Together May Help Save Voicebox
(Posted: 05/14/2002, Reviewed: 04/05/2005) - People with cancer of the larynx often face laryngectomy -- surgery to remove the voicebox -- to help stop the spread of the cancer. Now, a new study shows that giving chemotherapy and radiation therapy together can put off the need for a laryngectomy and preserve use of the voicebox longer than the currently established practice of giving chemotherapy followed by radiation.
< Previous  1 2 

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov